{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,7]],"date-time":"2026-03-07T14:58:35Z","timestamp":1772895515251,"version":"3.50.1"},"reference-count":95,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2003,6,1]],"date-time":"2003-06-01T00:00:00Z","timestamp":1054425600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Am J Respir Med"],"published-print":{"date-parts":[[2003,6]]},"DOI":"10.1007\/bf03256653","type":"journal-article","created":{"date-parts":[[2012,8,23]],"date-time":"2012-08-23T04:27:46Z","timestamp":1345696066000},"page":"245-259","source":"Crossref","is-referenced-by-count":56,"title":["Anti-Interleukin-5 Monoclonal Antibodies"],"prefix":"10.1007","volume":"2","author":[{"given":"Maggie J.","family":"Leckie","sequence":"first","affiliation":[]}],"member":"297","published-online":{"date-parts":[[2012,8,20]]},"reference":[{"issue":"1","key":"BF03256653_CR1","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1093\/oxfordjournals.bmb.a072541","volume":"48","author":"AB Kay","year":"1992","unstructured":"Kay AB, Corrigan CJ. Asthma: eosinophils and neutrophils. Br Med Bull 1992; 48(1): 51\u201364","journal-title":"Br Med Bull"},{"issue":"22","key":"BF03256653_CR2","doi-asserted-by":"crossref","first-page":"1592","DOI":"10.1056\/NEJM199805283382206","volume":"338","author":"ME Rothenberg","year":"1998","unstructured":"Rothenberg ME. Eosinophilia. N Engl J Med 1998; 338(22): 1592\u2013600","journal-title":"N Engl J Med"},{"key":"BF03256653_CR3","doi-asserted-by":"crossref","first-page":"216","DOI":"10.1016\/S0031-6997(24)01404-2","volume":"51","author":"MA Giembycz","year":"1999","unstructured":"Giembycz MA, Lindsay MA. Pharmacology of the eosinophil. Pharmacol Rev 1999; 51: 216\u2013309","journal-title":"Pharmacol Rev"},{"key":"BF03256653_CR4","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1111\/j.1365-2222.1985.tb02290.x","volume":"15","author":"SR Durham","year":"1985","unstructured":"Durham SR, Kay AB. Eosinophils, bronchial hyperreactivity and late-phase asthmatic reactions. Clin Allergy 1985; 15: 411\u20138","journal-title":"Clin Allergy"},{"key":"BF03256653_CR5","doi-asserted-by":"crossref","first-page":"310","DOI":"10.1136\/thx.52.4.310","volume":"52","author":"AE Redington","year":"1997","unstructured":"Redington AE, Howarth PH. Airway wall remodelling in asthma. Thorax 1997; 52: 310\u20132","journal-title":"Thorax"},{"key":"BF03256653_CR6","doi-asserted-by":"crossref","first-page":"661","DOI":"10.1111\/j.1365-2222.1990.tb02705.x","volume":"20","author":"PG Gibson","year":"1990","unstructured":"Gibson PG, Dolovich J, Girgis-Gabardo A, et al. The inflammatory response in asthma exacerbation: changes in circulating eosinophils, basophils and their progenitors. Clin Exp Allergy 1990; 20: 661\u20138","journal-title":"Clin Exp Allergy"},{"key":"BF03256653_CR7","doi-asserted-by":"crossref","first-page":"3101","DOI":"10.1182\/blood.V79.12.3101.bloodjournal79123101","volume":"79","author":"CJ Sanderson","year":"1992","unstructured":"Sanderson CJ. Interleukin-5, eosinophils and disease. Blood 1992; 79: 3101\u20139","journal-title":"Blood"},{"issue":"1","key":"BF03256653_CR8","doi-asserted-by":"crossref","first-page":"S55","DOI":"10.1016\/0090-1229(92)90041-L","volume":"62","author":"PF Weller","year":"1992","unstructured":"Weller PF. Cytokine regulation of eosinophil function. Clin Immunopathol 1992; 62 (1 Pt 2): S55\u20139","journal-title":"Clin Immunopathol"},{"key":"BF03256653_CR9","doi-asserted-by":"crossref","first-page":"314","DOI":"10.1046\/j.1365-2222.1999.00390.x","volume":"29","author":"M Lampinen","year":"1999","unstructured":"Lampinen M, Rak S, Venge J. The role of interleukin-5, interleukin-8 and RANTES in the chemotactic attraction of eosinophils to the allergic lung. Clin Exp Allergy 1999; 29: 314\u201322","journal-title":"Clin Exp Allergy"},{"key":"BF03256653_CR10","doi-asserted-by":"crossref","first-page":"540","DOI":"10.1164\/ajrccm\/147.3.540","volume":"147","author":"CJ Corrigan","year":"1993","unstructured":"Corrigan CJ, Haczku A, Gemou-Engesaeth V, et al. CD4 T-lymphocyte activation in asthma is accompanied by increased serum concentrations of interleukin-5. Am Rev Respir Dis 1993; 147: 540\u20137","journal-title":"Am Rev Respir Dis"},{"key":"BF03256653_CR11","doi-asserted-by":"crossref","first-page":"704","DOI":"10.1164\/ajrccm.156.3.9610033","volume":"156","author":"M Humbert","year":"1997","unstructured":"Humbert M, Corrigan CJ, Kimmitt P, et al. Relationship between IL-4 and IL-5 mRNA expression and disease severity in atopic asthma. Am J Respir Crit Care Med 1997; 156: 704\u20138","journal-title":"Am J Respir Crit Care Med"},{"key":"BF03256653_CR12","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1046\/j.1365-2222.1999.00466.x","volume":"29","author":"MJ Veen van der","year":"1999","unstructured":"van der Veen MJ, van Neerven RJJ, de Jong EC, et al. The late asthmatic response is associated with baseline allergen-specific proliferative responsiveness of peripheral T lymphocytes in vitro and serum interleukin-5. Clin Exp Allergy 1999; 29: 217\u201327","journal-title":"Clin Exp Allergy"},{"issue":"1","key":"BF03256653_CR13","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1159\/000237234","volume":"109","author":"S Konno","year":"1996","unstructured":"Konno S, Gonokami Y, Kurokawa M, et al. Cytokine concentrations in sputum of asthmatic patients. Int Arch Allergy Immunol 1996; 109(1): 73\u20138","journal-title":"Int Arch Allergy Immunol"},{"issue":"5","key":"BF03256653_CR14","doi-asserted-by":"crossref","first-page":"661","DOI":"10.1016\/S0091-6749(95)70265-2","volume":"96","author":"S Sur","year":"1995","unstructured":"Sur S, Gleich GJ, Swanson MC, et al. Eosinophilic inflammation is associated with elevation of interleukin-5 in the airways of patients with spontaneous symptomatic asthma. J Allergy Clin Immunol 1995; 96 (5 Pt 1): 661\u20138","journal-title":"J Allergy Clin Immunol"},{"key":"BF03256653_CR15","doi-asserted-by":"crossref","first-page":"204","DOI":"10.1164\/ajrccm.157.1.9703027","volume":"157","author":"HZ Shi","year":"1998","unstructured":"Shi HZ, Xiao C-Q, Zhong D, et al. Effect of inhaled interleukin-5 on airway hyperreactivity and eosinophilia in asthmatics. Am J Respir Crit Care Med 1998; 157: 204\u20139","journal-title":"Am J Respir Crit Care Med"},{"key":"BF03256653_CR16","first-page":"299","volume-title":"Interleukin-5 from molecule to drug target for asthma: in lung biology in health and disease","author":"M McKinnon","year":"1999","unstructured":"McKinnon M, Banks M, Solari R, et al. Interleukin-5 and the interleukin-5 receptor: targets for drug discovery in asthma. In: Sanderson CJ, editor. Interleukin-5 from molecule to drug target for asthma: in lung biology in health and disease. New York: Marcel Dekker, 1999: 299\u2013320"},{"issue":"3","key":"BF03256653_CR17","doi-asserted-by":"crossref","first-page":"548","DOI":"10.1164\/ajrccm\/147.3.548","volume":"147","author":"AJ Oosterhout Van","year":"1993","unstructured":"Van Oosterhout AJ, Ladenius AR, Savelkoul HF, et al. Effect of anti-IL-5 and IL-5 on airway hyperreactivity and eosinophils in guinea pigs. Am Rev Respir Dis 1993; 147(3): 548\u201352","journal-title":"Am Rev Respir Dis"},{"key":"BF03256653_CR18","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1084\/jem.183.1.195","volume":"183","author":"PS Foster","year":"1996","unstructured":"Foster PS, Hogan SP, Ramsay AJ, et al. Interleukin-5 deficiency abolishes eosinophilia, airways hyperreactivity, and lung damage in a mouse asthma model. J Exp Med 1996; 183: 195\u2013201","journal-title":"J Exp Med"},{"key":"BF03256653_CR19","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1016\/S0065-2776(08)60673-2","volume":"57","author":"K Takatsu","year":"1994","unstructured":"Takatsu K, Takaki S, Hitoshi Y. Interleukin-5 and its receptor system: implications in the immune system and inflammation. Adv Immunol 1994; 57: 145\u201390","journal-title":"Adv Immunol"},{"issue":"7","key":"BF03256653_CR20","doi-asserted-by":"crossref","first-page":"3792","DOI":"10.4049\/jimmunol.167.7.3792","volume":"167","author":"M Hertz","year":"2001","unstructured":"Hertz M, Mahalingam S, Dalum I, et al. Active vaccination against IL-5 bypasses immunological tolerance and ameliorates experimental asthma. J Immunol 2001; 167(7): 3792\u20139","journal-title":"J Immunol"},{"key":"BF03256653_CR21","doi-asserted-by":"crossref","first-page":"1837","DOI":"10.2174\/1381612023393800","volume":"8","author":"I Uings","year":"2002","unstructured":"Uings I, McKinnon. Development of IL-5 receptor antagonists. Curr Pharm Des 2002; 8: 1837\u201344","journal-title":"Curr Pharm Des"},{"issue":"2","key":"BF03256653_CR22","first-page":"469","volume":"54","author":"DI Pritchard","year":"1983","unstructured":"Pritchard DI, Eady RP, Harper ST, et al. Laboratory infection of primates with Ascaris suum to provide a model of allergic bronchoconstriction. Clin Exp Immunol 1983; 54(2): 469\u201376","journal-title":"Clin Exp Immunol"},{"issue":"10","key":"BF03256653_CR23","doi-asserted-by":"crossref","first-page":"1465","DOI":"10.1084\/jem.190.10.1465","volume":"190","author":"DJ Adamko","year":"1999","unstructured":"Adamko DJ, Yost BL, Gleich GJ, et al. Ovalbumin sensitization changes the inflammatory response to subsequent parainfluenza infection. Eosinophils mediate airway hyperresponsiveness, m(2) muscarinic receptor dysfunction, and antiviral effects. J Exp Med 1999; 190(10): 1465\u201378","journal-title":"J Exp Med"},{"issue":"3","key":"BF03256653_CR24","doi-asserted-by":"crossref","first-page":"284","DOI":"10.1038\/icb.1997.43","volume":"75","author":"SP Hogan","year":"1997","unstructured":"Hogan SP, Koskinen A, Foster PS. Interleukin-5 and eosinophils induce airway damage and bronchial hyperreactivity during allergic airway inflammation in BALB\/c mice. Immunol Cell Biol 1997; 75(3): 284\u20138","journal-title":"Immunol Cell Biol"},{"issue":"1","key":"BF03256653_CR25","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1016\/S0091-6749(99)70138-7","volume":"104","author":"FR Shardonofsky","year":"1999","unstructured":"Shardonofsky FR, Venzor III J, Barrios R, et al. Therapeutic efficacy of an anti-IL-5 monoclonal antibody delivered into the respiratory tract in a murine model of asthma. J Allergy Clin Immunol 1999; 104(1): 215\u201321","journal-title":"J Allergy Clin Immunol"},{"issue":"3","key":"BF03256653_CR26","doi-asserted-by":"crossref","first-page":"873","DOI":"10.1164\/ajrccm.151.3.7881685","volume":"151","author":"J Buijs","year":"1995","unstructured":"Buijs J, Egbers MW, Lokhorst WH, et al. Toxocara-induced eosinophilic inflammation. Airway function and effect of anti-IL-5. Am J Respir Crit Care Med 1995; 151 (3 Pt 1): 873\u20138","journal-title":"Am J Respir Crit Care Med"},{"key":"BF03256653_CR27","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1111\/j.1749-6632.1996.tb32570.x","volume":"796","author":"H Nagai","year":"1996","unstructured":"Nagai H, Yamaguchi S, Tanaka H. The role of interleukin-5 (IL-5) in allergic airway hyperresponsiveness in mice. Ann N Y Acad Sci 1996; 796: 91\u20136","journal-title":"Ann N Y Acad Sci"},{"issue":"3","key":"BF03256653_CR28","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1172\/JCI7010","volume":"104","author":"G Cieslewicz","year":"1999","unstructured":"Cieslewicz G, Tomkinson A, Adler A, et al. The late, but not early, asthmatic response is dependent on IL-5 and correlates with eosinophil infiltration. J Clin Invest 1999; 104(3): 301\u20138","journal-title":"J Clin Invest"},{"issue":"1","key":"BF03256653_CR29","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1016\/0014-2999(92)90273-7","volume":"211","author":"N Chand","year":"1992","unstructured":"Chand N, Harrison JE, Rooney S, et al. Anti-IL-5 monoclonal antibody inhibits allergic late phase bronchial eosinophilia in guinea pigs: a therapeutic approach. Eur J Pharmacol 1992; 211(1): 121\u20133","journal-title":"Eur J Pharmacol"},{"issue":"1-2","key":"BF03256653_CR30","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1016\/0165-2478(94)00241-I","volume":"45","author":"I Akutsu","year":"1995","unstructured":"Akutsu I, Kojima T, Kariyone A, et al. Antibody against interleukin-5 prevents antigen-induced eosinophil infiltration and bronchial hyperreactivity in the guinea pig airways. Immunol Lett 1995; 45(1-2): 109\u201316","journal-title":"Immunol Lett"},{"key":"BF03256653_CR31","doi-asserted-by":"crossref","first-page":"1623","DOI":"10.1164\/ajrccm\/148.6_Pt_1.1623","volume":"148","author":"PJ Mauser","year":"1993","unstructured":"Mauser PJ, Pitman A, Witt A, et al. Inhibitory effect of the TRFK-5 anti-IL-5 antibody in a guinea pig model of asthma. Am Rev Respir Dis 1993; 148: 1623\u20137","journal-title":"Am Rev Respir Dis"},{"key":"BF03256653_CR32","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1164\/ajrccm.151.1.7812550","volume":"151","author":"AJM Oosterhout Van","year":"1995","unstructured":"Van Oosterhout AJM, Van Ark I, Folkerts G, et al. Antibody to interleukin-5 inhibits virus-induced airway hyperresponsiveness to histamine in guinea pigs. Am J Respir Crit Care Med 1995; 151: 177\u201383","journal-title":"Am J Respir Crit Care Med"},{"key":"BF03256653_CR33","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1164\/ajrccm.152.2.7633694","volume":"152","author":"PJ Mauser","year":"1995","unstructured":"Mauser PJ, Pitman AM, Fernandez X, et al. Effects of an antibody to interleukin-5 in a monkey model of asthma. Am J Respir Crit Care Med 1995; 152: 467\u201372","journal-title":"Am J Respir Crit Care Med"},{"issue":"Suppl.2","key":"BF03256653_CR34","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1590\/S0074-02761997000800011","volume":"92","author":"RW Egan","year":"1997","unstructured":"Egan RW, Athwahl D, Chou CC, et al. Pulmonary biology of anti-interleukin 5 antibodies. Mem Inst Oswaldo Cruz 1997; 92 Suppl. 2: 69\u201373","journal-title":"Mem Inst Oswaldo Cruz"},{"issue":"2","key":"BF03256653_CR35","doi-asserted-by":"crossref","first-page":"250","DOI":"10.1067\/mai.2001.116576","volume":"108","author":"TK Hart","year":"2001","unstructured":"Hart TK, Cook RM, Zia-Amirhosseini P, et al. Preclinical efficacy and safety of mepolizumab (SB-240563), a humanized monoclonal antibody to IL-5, in cynomolgus monkeys. J Allergy Clin Immunol 2001; 108(2): 250\u20137","journal-title":"J Allergy Clin Immunol"},{"key":"BF03256653_CR36","doi-asserted-by":"crossref","first-page":"1289","DOI":"10.1164\/ajrccm\/145.6.1289","volume":"145","author":"W Elwood","year":"1992","unstructured":"Elwood W, L\u00f6tvall JO, Barnes PJ, et al. Effect of dexamethasone and cyclosporin A on allergen-induced airway hyperresponsiveness and inflammatory cell responses in sensitized Brown-Norway rats. Am Rev Respir Dis 1992; 145: 1289\u201394","journal-title":"Am Rev Respir Dis"},{"key":"BF03256653_CR37","doi-asserted-by":"crossref","first-page":"1501","DOI":"10.4049\/jimmunol.161.3.1501","volume":"161","author":"SP Hogan","year":"1998","unstructured":"Hogan SP, Matthaei KI, Young JM, et al. A novel T cell-regulated mechanism modulating allergen-induced airways hyperreactivity in balb\/c mice independently of IL-4 and IL-5. J Immunol 1998; 161: 1501\u20139","journal-title":"J Immunol"},{"key":"BF03256653_CR38","first-page":"169","volume":"62","author":"H Tanaka","year":"1997","unstructured":"Tanaka H, Nagai H, Maeda Y. Effect of anti-IL-4 and anti-IL-5 antibodies on allergic airway hyperresponsiveness in mice. Life Sci 1997; 62: 169\u201374","journal-title":"Life Sci"},{"issue":"9","key":"BF03256653_CR39","first-page":"779","volume":"49","author":"RW Egan","year":"1999","unstructured":"Egan RW, Athwal D, Bodmer MW, et al. Effect of Sch 55700, a humanized monoclonal antibody to human interleukin-5, on eosinophilic responses and bronchial hyperreactivity. Arzneimittelforschung 1999; 49(9): 779\u201390","journal-title":"Arzneimittelforschung"},{"issue":"6","key":"BF03256653_CR40","first-page":"857","volume":"55","author":"DW Cockcroft","year":"1985","unstructured":"Cockcroft DW. The bronchial late response in the pathogenesis of asthma and its modulation by therapy. Ann Allergy 1985; 55(6): 857\u201362","journal-title":"Ann Allergy"},{"issue":"3","key":"BF03256653_CR41","doi-asserted-by":"crossref","first-page":"740","DOI":"10.1164\/ajrccm\/136.3.740","volume":"136","author":"PM O\u2019Byrne","year":"1987","unstructured":"O\u2019Byrne PM, Dolovich J, Hargreave FE. Late asthmatic responses. Am Rev Respir Dis 1987; 136(3): 740\u201351","journal-title":"Am Rev Respir Dis"},{"issue":"1","key":"BF03256653_CR42","first-page":"264","volume":"135","author":"DW Cockcroft","year":"1987","unstructured":"Cockcroft DW, Murdock KY, Kirby J, et al. Prediction of airway responsiveness to allergen from skin sensitivity to allergen and airway responsiveness to histamine. Am Rev Respir Dis 1987; 135(1): 264\u20137","journal-title":"Am Rev Respir Dis"},{"issue":"4","key":"BF03256653_CR43","doi-asserted-by":"crossref","first-page":"244","DOI":"10.1016\/0091-6749(74)90067-0","volume":"54","author":"DG Robertson","year":"1974","unstructured":"Robertson DG, Kerigan AT, Hargreave FE, et al. Late asthmatic responses induced by ragweed pollen allergen. J Allergy Clin Immunol 1974; 54(4): 244\u201354","journal-title":"J Allergy Clin Immunol"},{"issue":"6","key":"BF03256653_CR44","doi-asserted-by":"crossref","first-page":"1274","DOI":"10.1164\/ajrccm\/144.6.1274","volume":"144","author":"JB Sedgwick","year":"1991","unstructured":"Sedgwick JB, Calhoun WJ, Gleich GJ, et al. Immediate and late airway response of allergic rhinitis patients to segmental antigen challenge: characterization of eosinophil and mast cell mediators. Am Rev Respir Dis 1991; 144(6): 1274\u201381","journal-title":"Am Rev Respir Dis"},{"key":"BF03256653_CR45","doi-asserted-by":"crossref","first-page":"2149","DOI":"10.1016\/S0140-6736(00)03497-8","volume":"356","author":"SA Bryan","year":"2000","unstructured":"Bryan SA, O\u2019Connor BJ, Matti S, et al. Effects of recombinant human interleukin-12 on eosinophils, airway hyper-responsiveness, and the late asthmatic response. Lancet 2000; 356: 2149\u201353","journal-title":"Lancet"},{"issue":"9","key":"BF03256653_CR46","doi-asserted-by":"crossref","first-page":"1235","DOI":"10.1046\/j.1365-2222.2000.00860.x","volume":"30","author":"GM Gauvreau","year":"2000","unstructured":"Gauvreau GM, Sulakvelidze I, Watson RM, et al. Effects of once daily dosing with inhaled budesonide on airway hyperresponsiveness and airway inflammation following repeated low-dose allergen challenge in atopic asthmatics. Clin Exp Allergy 2000; 30(9): 1235\u201343","journal-title":"Clin Exp Allergy"},{"key":"BF03256653_CR47","doi-asserted-by":"crossref","first-page":"2144","DOI":"10.1016\/S0140-6736(00)03496-6","volume":"356","author":"MJ Leckie","year":"2000","unstructured":"Leckie MJ, ten Brinke A, Khan J, et al. Effects of an interleukin-5 blocking monoclonal antibody on eosinophils, airway hyperresponsiveness and the late asthmatic response. Lancet 2000; 356: 2144\u20138","journal-title":"Lancet"},{"key":"BF03256653_CR48","volume-title":"American Thoracic Society Annual Meeting","author":"CO Compton","year":"2001","unstructured":"Compton CO. Mepoluzimab: clinical experience [oral presentation]. American Thoracic Society Annual Meeting. 2001 May 18\u201323; San Francisco, CA"},{"issue":"2","key":"BF03256653_CR49","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1164\/rccm.200208-789OC","volume":"167","author":"PT Flood-Page","year":"2003","unstructured":"Flood-Page PT, Menzies-Gow AN, Kay AB, et al. Eosinophil\u2019s role remains uncertain as anti-interleukin-5 only partially depletes numbers in asthmatic airway. Am J Respir Crit Care Med 2003; 167(2): 199\u2013204","journal-title":"Am J Respir Crit Care Med"},{"key":"BF03256653_CR50","first-page":"A505","volume":"161","author":"JC Kips","year":"2000","unstructured":"Kips JC, O\u2019Connor BJ, Langley SJ, et al. Results of a phase 1 trial with SCH55700, a humanized anti-IL-5 antibody, in severe, persistent asthma [abstract]. Am J Respir Crit Care Med 2000; 161: A505","journal-title":"Am J Respir Crit Care Med"},{"key":"BF03256653_CR51","doi-asserted-by":"crossref","first-page":"652","DOI":"10.1183\/09031936.97.10030652","volume":"10","author":"J Palen van der","year":"1997","unstructured":"van der Palen J, Klein JJ, Rovers MM. Compliance with inhaled medication and self-treatment guidelines following a self-management programme in adult asthmatics. Eur Respir J 1997; 10: 652\u20137","journal-title":"Eur Respir J"},{"issue":"4","key":"BF03256653_CR52","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1067\/mai.2001.119149","volume":"108","author":"PM O\u2019Byrne","year":"2001","unstructured":"O\u2019Byrne PM, Inman MD, Parameswaran K. The trials and tribulations of IL-5, eosinophils, and allergic asthma. J Allergy Clin Immunol 2001; 108(4): 503\u20138","journal-title":"J Allergy Clin Immunol"},{"key":"BF03256653_CR53","doi-asserted-by":"crossref","first-page":"1470","DOI":"10.1172\/JCI115155","volume":"87","author":"RH Gundel","year":"1991","unstructured":"Gundel RH, Letts LG, Gleich GJ. Human eosinophil major basic protein induces airway constriction and airway hyperresponsiveness in primates. J Clin Invest 1991; 87: 1470\u20133","journal-title":"J Clin Invest"},{"issue":"Suppl.2","key":"BF03256653_CR54","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1046\/j.1365-2222.1999.00010.x","volume":"29","author":"DB Jacoby","year":"1999","unstructured":"Jacoby DB, Fryer AD. Interaction of viral infections with muscarinic receptors. Clin Exp Allergy 1999; 29 Suppl. 2: 59\u201364","journal-title":"Clin Exp Allergy"},{"key":"BF03256653_CR55","doi-asserted-by":"crossref","first-page":"1191","DOI":"10.1016\/S0091-6749(95)70075-7","volume":"95","author":"MD Inman","year":"1995","unstructured":"Inman MD, Watson RM, Cockcroft DW, et al. Reproducibility of allergen-induced early and late asthmatic responses. J Allergy Clin Immunol 1995; 95: 1191\u20135","journal-title":"J Allergy Clin Immunol"},{"issue":"6","key":"BF03256653_CR56","doi-asserted-by":"crossref","first-page":"1274","DOI":"10.1164\/ajrccm\/144.6.1274","volume":"144","author":"JB Sedgwick","year":"1991","unstructured":"Sedgwick JB, Calhoun WJ, Gleich GJ, et al. Immediate and late airway response of allergic rhinitis patients to segmental antigen challenge: characterization of eosinophil and mast cell mediators. Am Rev Respir Dis 1991; 144(6): 1274\u201381","journal-title":"Am Rev Respir Dis"},{"key":"BF03256653_CR57","doi-asserted-by":"crossref","first-page":"2149","DOI":"10.1016\/S0140-6736(00)03497-8","volume":"356","author":"SA Bryan","year":"2000","unstructured":"Bryan SA, O\u2019Connor BJ, Matti S, et al. Effects of recombinant human interleukin-12 on eosinophils, airway hyperreactivity and the late asthmatic response. Lancet 2000; 356: 2149\u201353","journal-title":"Lancet"},{"issue":"3","key":"BF03256653_CR58","doi-asserted-by":"crossref","first-page":"758","DOI":"10.1016\/0091-6749(93)90196-M","volume":"91","author":"BA Muller","year":"1993","unstructured":"Muller BA, Leick CA, Smith RM, et al. Comparisons of specific and nonspecific bronchoprovocation in subjects with asthma, rhinitis, and healthy subjects. J Allergy Clin Immunol 1993; 91(3): 758\u201372","journal-title":"J Allergy Clin Immunol"},{"key":"BF03256653_CR59","doi-asserted-by":"crossref","first-page":"1828","DOI":"10.1164\/ajrccm.155.6.9196082","volume":"155","author":"JV Fahy","year":"1997","unstructured":"Fahy JV, Fleming HE, Wong HH, et al. The effect of an anti-IgE monoclonal antibody on the early- and late-phase responses to allergen inhalation in asthmatic subjects. Am J Respir Crit Care Med 1997; 155: 1828\u201334","journal-title":"Am J Respir Crit Care Med"},{"issue":"Suppl.1","key":"BF03256653_CR60","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1046\/j.1365-2222.2000.00091.x","volume":"30","author":"JV Fahy","year":"2000","unstructured":"Fahy JV. Reducing IgE levels as a strategy for the treatment of asthma. Clin Exp Allergy 2000; 30 Suppl. 1: 16\u201321","journal-title":"Clin Exp Allergy"},{"issue":"5","key":"BF03256653_CR61","doi-asserted-by":"crossref","first-page":"1600","DOI":"10.1182\/blood.V95.5.1600.005k22_1600_1607","volume":"95","author":"J Tavernier","year":"2000","unstructured":"Tavernier J, Van der Heyden J, Verhee A, et al. Interleukin 5 regulates the isoform expression of its own receptor alpha-subunit. Blood 2000; 95(5): 1600\u20137","journal-title":"Blood"},{"key":"BF03256653_CR62","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1164\/ajrccm.157.1.9703002","volume":"157","author":"E Crimi","year":"1998","unstructured":"Crimi E, Spanvello A, Neri M, et al. Dissociation between airway inflammation and airway hyperresponsiveness in allergic asthma. Am J Respir Crit Care Med 1998; 157: 4\u20139","journal-title":"Am J Respir Crit Care Med"},{"key":"BF03256653_CR63","doi-asserted-by":"crossref","first-page":"232","DOI":"10.1016\/S0091-6749(99)70496-3","volume":"103","author":"E Rosi","year":"1999","unstructured":"Rosi E, Ronchi MC, Grazzini M, et al. Sputum analysis, bronchial hyperresponsiveness, and airway function in asthma: results of a factor analysis. J Allergy Clin Immunol 1999; 103: 232\u20137","journal-title":"J Allergy Clin Immunol"},{"issue":"3","key":"BF03256653_CR64","doi-asserted-by":"crossref","first-page":"394","DOI":"10.1067\/mai.2001.117460","volume":"108","author":"BM Haselden","year":"2001","unstructured":"Haselden BM, Larche M, Meng Q, et al. Late asthmatic reactions provoked by intradermal injection of T-cell peptide epitopes are not associated with bronchial mucosal infiltration of eosinophils or T(H)2-type cells or with elevated concentrations of histamine or eicosanoids in bronchoalveolar fluid. J Allergy Clin Immunol 2001; 108(3): 394\u2013401","journal-title":"J Allergy Clin Immunol"},{"key":"BF03256653_CR65","doi-asserted-by":"crossref","first-page":"1267","DOI":"10.1164\/ajrccm.154.5.8912734","volume":"154","author":"GM Gauvreau","year":"1996","unstructured":"Gauvreau GM, Doctor J, Watson RM, et al. Effects of inhaled budesonide on allergen-induced airway responses and airway inflammation. Am J Respir Crit Care Med 1996; 154: 1267\u201371","journal-title":"Am J Respir Crit Care Med"},{"issue":"10","key":"BF03256653_CR66","doi-asserted-by":"crossref","first-page":"2727","DOI":"10.1002\/eji.1830251002","volume":"25","author":"S Till","year":"1995","unstructured":"Till S, Li B, Durham S, et al. Secretion of the eosinophil-active cytokines interleukin-5, granulocyte\/macrophage colony-stimulating factor and interleukin-3 by bronchoalveolar lavage CD4+ and CD8+ T cell lines in atopic asthmatics, and atopic and non-atopic controls. Eur J Immunol 1995; 25(10): 2727\u201331","journal-title":"Eur J Immunol"},{"issue":"5","key":"BF03256653_CR67","doi-asserted-by":"crossref","first-page":"567","DOI":"10.1165\/ajrcmb.12.5.7742019","volume":"12","author":"CJ Corrigan","year":"1995","unstructured":"Corrigan CJ, Hamid Q, North J, et al. Peripheral blood CD4 but not CD8 t-lymphocytes in patients with exacerbation of asthma transcribe and translate messenger RNA encoding cytokines which prolong eosinophil survival in the context of a Th2-type pattern: effect of glucocorticoid therapy. Am J Respir Cell Mol Biol 1995; 12(5): 567\u201378","journal-title":"Am J Respir Cell Mol Biol"},{"issue":"6","key":"BF03256653_CR68","doi-asserted-by":"crossref","first-page":"1943","DOI":"10.1182\/blood.V94.6.1943","volume":"94","author":"Q Sun","year":"1999","unstructured":"Sun Q, Jones K, McClure B, et al. Simultaneous antagonism of interleukin-5, granulocyte-macrophage colony-stimulating factor, and interleukin-3 stimulation of human eosinophils by targetting the common cytokine binding site of their receptors. Blood 1999; 94(6): 1943\u201351","journal-title":"Blood"},{"key":"BF03256653_CR69","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1034\/j.1600-065X.2001.790117.x","volume":"179","author":"PS Foster","year":"2001","unstructured":"Foster PS, Mould AW, Yang M, et al. Elemental signals regulating eosinophil accumulation in the lung. Immunol Rev 2001; 179: 173\u201381","journal-title":"Immunol Rev"},{"issue":"5397","key":"BF03256653_CR70","doi-asserted-by":"crossref","first-page":"2258","DOI":"10.1126\/science.282.5397.2258","volume":"282","author":"M Wills-Karp","year":"1998","unstructured":"Wills-Karp M, Luyimbazi J, Xu X, et al. Interleukin-13: central mediator of allergic asthma. Science 1998; 282(5397): 2258\u201361","journal-title":"Science"},{"issue":"1","key":"BF03256653_CR71","doi-asserted-by":"crossref","first-page":"108","DOI":"10.4049\/jimmunol.165.1.108","volume":"165","author":"DC Webb","year":"2000","unstructured":"Webb DC, McKenzie AN, Koskinen AM, et al. Integrated signals between IL-13, IL-4, and IL-5 regulate airways hyperreactivity. J Immunol 2000; 165(1): 108\u201313","journal-title":"J Immunol"},{"key":"BF03256653_CR72","doi-asserted-by":"crossref","first-page":"1816","DOI":"10.1164\/ajrccm.160.6.9808146","volume":"160","author":"LC Borish","year":"1999","unstructured":"Borish LC, Nelson HS, Lanz MJ, et al. Interleukin-4 receptor in moderate atopic asthma: a phase I\/II randomized, placebo-controlled trial. Am J Respir Crit Care Med 1999; 160: 1816\u201323","journal-title":"Am J Respir Crit Care Med"},{"key":"BF03256653_CR73","doi-asserted-by":"crossref","first-page":"919","DOI":"10.4049\/jimmunol.161.2.919","volume":"161","author":"A Keane-Myers","year":"1998","unstructured":"Keane-Myers A, Wysocka M, Trinchieri G, et al. Resistance to antigen-induced airway hyperresponsiveness requires endogenous production of IL-12. J Immunol 1998; 161: 919\u201326","journal-title":"J Immunol"},{"key":"BF03256653_CR74","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1016\/S0091-6749(99)70472-0","volume":"103","author":"HZ Shi","year":"1999","unstructured":"Shi HZ, Chen Y-Q, Qin S-M. Inhaled il-5 increases concentrations of soluble intracellular adhesion molecule-1 in sputum from atopic asthmatic subjects. J Allergy Clin Immunol 1999; 103: 463\u20137","journal-title":"J Allergy Clin Immunol"},{"issue":"3","key":"BF03256653_CR75","doi-asserted-by":"crossref","first-page":"1132","DOI":"10.1164\/ajrccm.162.3.9910100","volume":"162","author":"A Kanehiro","year":"2000","unstructured":"Kanehiro A, Takeda K, Joetham A, et al. Timing of administration of anti-VLA-4 differentiates airway hyperresponsiveness in the central and peripheral airways in mice. Am J Respir Crit Care Med 2000; 162 (3 Pt 1): 1132\u20139","journal-title":"Am J Respir Crit Care Med"},{"issue":"6","key":"BF03256653_CR76","doi-asserted-by":"crossref","first-page":"3385","DOI":"10.4049\/jimmunol.164.6.3385","volume":"164","author":"IS Douglas","year":"2000","unstructured":"Douglas IS, Leff AR, Sperling AI. CD4+ T cell and eosinophil adhesion is mediated by specific ICAM-3 ligation and results in eosinophil activation. J Immunol 2000; 164(6): 3385\u201391","journal-title":"J Immunol"},{"issue":"1","key":"BF03256653_CR77","doi-asserted-by":"crossref","first-page":"S99","DOI":"10.1067\/mai.2000.106884","volume":"106","author":"J Chihara","year":"2000","unstructured":"Chihara J, Kakazu T, Higashimoto I, et al. Signaling through the beta2 integrin prolongs eosinophil survival. J Allergy Clin Immunol 2000; 106 (1 Pt 2): S99\u2013103","journal-title":"J Allergy Clin Immunol"},{"key":"BF03256653_CR78","doi-asserted-by":"crossref","first-page":"881","DOI":"10.1084\/jem.179.3.881","volume":"179","author":"PJ Jose","year":"1994","unstructured":"Jose PJ, Griffiths-Johnson DA, Collins PD, et al. Eotaxin: a potent eosinophil chemoattractant cytokine detected in a guinea pig model for allergic airways inflammation. J Exp Med 1994; 179: 881\u20137","journal-title":"J Exp Med"},{"issue":"2","key":"BF03256653_CR79","doi-asserted-by":"crossref","first-page":"640","DOI":"10.1164\/ajrccm.160.2.9809130","volume":"160","author":"GM Gauvreau","year":"1999","unstructured":"Gauvreau GM, Watson RM, O\u2019Byrne PM. Kinetics of allergen-induced airway eosinophilic cytokine production and airway inflammation. Am J Respir Crit Care Med 1999; 160(2): 640\u20137","journal-title":"Am J Respir Crit Care Med"},{"issue":"1","key":"BF03256653_CR80","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1517\/13543784.9.1.43","volume":"9","author":"CP Bertrand","year":"2000","unstructured":"Bertrand CP, Ponath PD. CCR3 blockade as a new therapy for asthma. Expert Opin Investig Drugs 2000; 9(1): 43\u201352","journal-title":"Expert Opin Investig Drugs"},{"issue":"6","key":"BF03256653_CR81","doi-asserted-by":"crossref","first-page":"3418","DOI":"10.4049\/jimmunol.165.6.3418","volume":"165","author":"K Dabbagh","year":"2000","unstructured":"Dabbagh K, Xiao Y, Smith C, et al. Local blockade of allergic airway hyperreactivity and inflammation by the poxvirus-derived pan-CC-chemokine inhibitor vCCI. J Immunol 2000; 165(6): 3418\u201322","journal-title":"J Immunol"},{"issue":"26","key":"BF03256653_CR82","doi-asserted-by":"crossref","first-page":"1966","DOI":"10.1056\/NEJM199912233412603","volume":"341","author":"H Milgrom","year":"1999","unstructured":"Milgrom H, Fick Jr RB, Su JQ, et al. Treatment of allergic asthma with monoclonal anti-IgE antibody. rhuMAb- E25 Study Group. N Engl J Med 1999; 341(26): 1966\u201373","journal-title":"N Engl J Med"},{"issue":"2","key":"BF03256653_CR83","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1067\/mai.2001.117880","volume":"108","author":"W Busse","year":"2001","unstructured":"Busse W, Corren J, Lanier BQ, et al. Omalizumab, anti-IgE recombinant humanized monoclonal antibody, for the treatment of severe allergic asthma. J Allergy Clin Immunol 2001; 108(2): 184\u201390","journal-title":"J Allergy Clin Immunol"},{"issue":"2","key":"BF03256653_CR84","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1038\/72601","volume":"18","author":"TW Chang","year":"2000","unstructured":"Chang TW. The pharmacological basis of anti-IgE therapy. Nat Biotechnol 2000; 18(2): 157\u201362","journal-title":"Nat Biotechnol"},{"key":"BF03256653_CR85","doi-asserted-by":"crossref","first-page":"450","DOI":"10.1067\/mai.2003.169","volume":"111","author":"M Larche","year":"2003","unstructured":"Larche M, Robinson DS, Kay AB. The role of T lymphocytes in the pathogenesis of asthma. J Allergy Clin Immunol 2003; 111: 450\u201363","journal-title":"J Allergy Clin Immunol"},{"issue":"4","key":"BF03256653_CR86","doi-asserted-by":"crossref","first-page":"949","DOI":"10.1183\/09031936.98.11040949","volume":"11","author":"LA Stanciu","year":"1998","unstructured":"Stanciu LA, Djukanovic R. The role of ICAM-1 on T-cells in the pathogenesis of asthma. Eur Respir J 1998; 11(4): 949\u201357","journal-title":"Eur Respir J"},{"issue":"9134","key":"BF03256653_CR87","doi-asserted-by":"crossref","first-page":"1109","DOI":"10.1016\/S0140-6736(97)12261-9","volume":"352","author":"OM Kon","year":"1998","unstructured":"Kon OM, Sihra BS, Compton CH, et al. Randomised, dose-ranging, placebo-controlled study of chimeric antibody to CD4 (keliximab) in chronic severe asthma. Lancet 1998; 352(9134): 1109\u201313","journal-title":"Lancet"},{"issue":"10","key":"BF03256653_CR88","doi-asserted-by":"crossref","first-page":"516","DOI":"10.1007\/s000110050496","volume":"48","author":"OM Kon","year":"1999","unstructured":"Kon OM, Kay AB. Anti-T cell strategies in asthma. Inflamm Res 1999; 48(10): 516\u201323","journal-title":"Inflamm Res"},{"key":"BF03256653_CR89","doi-asserted-by":"crossref","first-page":"690","DOI":"10.1016\/0140-6736(91)90277-V","volume":"337","author":"IK Taylor","year":"1991","unstructured":"Taylor IK, O\u2019Shaughnessy KM, Fuller R, et al. Effect of cysteinyl-leukotriene receptor antagonist ICI 204.219 on allergen-induced bronchoconstriction and airway hyperreactivity in atopic subjects. Lancet 1991; 337: 690\u20134","journal-title":"Lancet"},{"key":"BF03256653_CR90","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1136\/thx.52.5.447","volume":"52","author":"BS Sihra","year":"1997","unstructured":"Sihra BS, Kon OM, Durham SR, et al. Effect of cyclosporin A on the allergen-induced late asthmatic reaction. Thorax 1997; 52: 447\u201352","journal-title":"Thorax"},{"issue":"Suppl.2","key":"BF03256653_CR91","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1590\/S0074-02761997000800020","volume":"92","author":"JP Viola","year":"1997","unstructured":"Viola JP, Rao A. Role of the cyclosporin-sensitive transcription factor NFAT1 in the allergic response. Mem Inst Oswaldo Cruz 1997; 92 Suppl. 2: 147\u201355","journal-title":"Mem Inst Oswaldo Cruz"},{"issue":"11","key":"BF03256653_CR92","doi-asserted-by":"crossref","first-page":"2383","DOI":"10.1002\/1529-0131(200011)43:11<2383::AID-ANR2>3.0.CO;2-D","volume":"43","author":"PJ Charles","year":"2000","unstructured":"Charles PJ, Smeenk RJ, De Jong J, et al. Assessment of antibodies to double-stranded DNA induced in rheumatoid arthritis patients following treatment with infliximab, a monoclonal antibody to tumor necrosis factor alpha: findings in open-label and randomized placebo-controlled trials. Arthritis Rheum 2000; 43(11): 2383\u201390","journal-title":"Arthritis Rheum"},{"key":"BF03256653_CR93","doi-asserted-by":"crossref","first-page":"7470","DOI":"10.4049\/jimmunol.162.12.7470","volume":"162","author":"Y Kato","year":"1999","unstructured":"Kato Y, Manabe T, Tanaka H, et al. Effect of orally active Th1\/Th2 balance modulator, M50367, on IgE production, eosinophilia, and airway hyperresponsiveness in mice. J Immunol 1999; 162: 7470\u20139","journal-title":"J Immunol"},{"issue":"8","key":"BF03256653_CR94","doi-asserted-by":"crossref","first-page":"1403","DOI":"10.1164\/ajrccm.164.8.2010002","volume":"164","author":"RG Stirling","year":"2001","unstructured":"Stirling RG, van Rensen EL, Barnes PJ, et al. Interleukin-5 induces CD34(+) eosinophil progenitor mobilization and eosinophil CCR3 expression in asthma. Am J Respir Crit Care Med 2001; 164(8 Pt 1): 1403\u20139.","journal-title":"Am J Respir Crit Care Med"},{"key":"BF03256653_CR95","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1183\/09031936.01.00064101","volume":"18","author":"OM Kon","year":"2001","unstructured":"Kon OM, Sihra BS, Loh L-C, et al. The effects of an anti-CD4 monoclonal antibody, keliximab, on peripheral blood CD4+ T-cells in asthma. Eur Respir J 2001; 18: 45\u201352","journal-title":"Eur Respir J"}],"container-title":["American Journal of Respiratory Medicine"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/BF03256653.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/BF03256653\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/BF03256653","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,4,7]],"date-time":"2025-04-07T03:41:03Z","timestamp":1743997263000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/BF03256653"}},"subtitle":["Preclinical and Clinical Evidence in Asthma Models"],"short-title":[],"issued":{"date-parts":[[2003,6]]},"references-count":95,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2003,6]]}},"alternative-id":["BF03256653"],"URL":"https:\/\/doi.org\/10.1007\/bf03256653","relation":{},"ISSN":["1175-6365"],"issn-type":[{"value":"1175-6365","type":"print"}],"subject":[],"published":{"date-parts":[[2003,6]]}}}